new glp 1 drug retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide vs. Tirzepatide: The Next-Gen

Schwabe, R

Integrated Care Models: Reimagining Obesity Treatment Why It Matters According to many, GLP-1 medications have revolutionized medical weight management, shifting it from a test of willpower to a science-backed biological intervention with predictable results

How to Reduce Tirzepatide Rashes and Itchy Injection Sites A deliberate rotation plan, small technique changes, and fast pattern-tracking are the most reliable ways to prevent recurring tirzepatide, Zepbound, or Mounjaro injection-site rashes, because they prevent concentrated trauma before the skin reacts

Current research provides reassurance: No evidence shows that GLP-1 therapy directly reduces testosterone levels

The standard starting dose is 0.5mg once weekly, with increases every four weeks following a structured schedule

This means running them together should not dramatically increase the burden of side effects compared to running either one alone